Food and Drug Regulations
C.02.012 (1) Every fabricator, packager/labeller, distributor referred to in section C.01A.003, importer and wholesaler of a drug shall maintain
(a) a system of control that permits complete and rapid recall of any lot or batch of the drug that is on the market; and
(b) a program of self-inspection.
(2) Every fabricator and packager/labeller and, subject to subsections (3) and (4), every distributor referred to in paragraph C.01A.003(b) and importer of a drug shall maintain a system designed to ensure that any lot or batch of the drug fabricated and packaged/labelled on premises other than their own is fabricated and packaged/labelled in accordance with the requirements of this Division.
(3) The distributor referred to in paragraph C.01A.003(b) of a drug that is fabricated, packaged/labelled and tested in Canada by a person who holds an establishment licence that authorizes those activities is not required to comply with the requirements of subsection (2) in respect of that drug.
(4) If a drug is fabricated or packaged/labelled in an MRA country at a recognized building, the distributor referred to in paragraph C.01A.003(b) or importer of the drug is not required to comply with the requirements of subsection (2) in respect of that activity for that drug if
(a) the address of the building is set out in that person’s establishment licence; and
(b) that person retains a copy of the batch certificate for each lot or batch of the drug received by that person.
- SOR/82-524, s. 3
- SOR/97-12, s. 13
- SOR/2000-120, s. 9
- SOR/2002-368, s. 9
- Date modified: